Correlation Between Merus BV and Kura Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merus BV and Kura Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merus BV and Kura Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merus BV and Kura Oncology, you can compare the effects of market volatilities on Merus BV and Kura Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merus BV with a short position of Kura Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merus BV and Kura Oncology.

Diversification Opportunities for Merus BV and Kura Oncology

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Merus and Kura is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Merus BV and Kura Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kura Oncology and Merus BV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merus BV are associated (or correlated) with Kura Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kura Oncology has no effect on the direction of Merus BV i.e., Merus BV and Kura Oncology go up and down completely randomly.

Pair Corralation between Merus BV and Kura Oncology

Given the investment horizon of 90 days Merus BV is expected to generate 0.4 times more return on investment than Kura Oncology. However, Merus BV is 2.48 times less risky than Kura Oncology. It trades about -0.08 of its potential returns per unit of risk. Kura Oncology is currently generating about -0.15 per unit of risk. If you would invest  5,047  in Merus BV on August 31, 2024 and sell it today you would lose (550.00) from holding Merus BV or give up 10.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Merus BV  vs.  Kura Oncology

 Performance 
       Timeline  
Merus BV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merus BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Kura Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kura Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Merus BV and Kura Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merus BV and Kura Oncology

The main advantage of trading using opposite Merus BV and Kura Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merus BV position performs unexpectedly, Kura Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kura Oncology will offset losses from the drop in Kura Oncology's long position.
The idea behind Merus BV and Kura Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios